Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.

about

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.

Item

http://www.wikidata.org/entity/Q45732943

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@en

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@nl

type

Item

label

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@en

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@nl

prefLabel

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@en

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@nl

P1476

Multimodality Imaging Approach ...... copy, FDG PET and Amyloid PET.

@en

P2093

Abass Alavi

http://www.w3.org/2001/XMLSchema#string

Chetsadaporn Promteangtrong

http://www.w3.org/2001/XMLSchema#string

Marcus Kolber

http://www.w3.org/2001/XMLSchema#string

Mateen Moghbel

http://www.w3.org/2001/XMLSchema#string

Priya Ramchandra

http://www.w3.org/2001/XMLSchema#string

Sina Houshmand

http://www.w3.org/2001/XMLSchema#string

Thomas J Werner

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Brain imaging in Alzheimer disease

Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature

18F-florbetaben Aβ imaging in mild cognitive impairment

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Magnetic resonance spectroscopy in AD.

Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease.

Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.

P304

330-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1590/1980-57642015DN94000330

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Schöll

Carlos Alberto Buchpiguel

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29213982

http://www.w3.org/2001/XMLSchema#string

P932

5619315

http://www.w3.org/2001/XMLSchema#string